OECD Reviews of Public Health: Japan
How to apply effective governance to harness the benefits of A.I. and mitigate its risks ...
Record details
Published: 3 August 2026
Source: OECD
Category: Policy
Topics: Regulation · Healthcare
Retrieved: 15 August 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Unsupervised Pattern Analysis in Japanese Veterinary Toxicology: A Regulatory-Compliant Framework for Cross-Species Risk Assessment
arXiv · 4 June 2026
Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; Other Policy Changes; and Adoption of Updated Versions of
US Federal Register · 4 August 2026
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
White House · 10 August 2026
Patient Experience AI
UK Contracts Finder — AI procurement · 12 August 2026
Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product
US Federal Register · 15 August 2026
Request for Information; Clinical Laboratory Improvement Amendments of 1988 (CLIA) Regulations
US Federal Register · 16 July 2026
How to cite this record
ethics.ai (3 August 2026), “OECD Reviews of Public Health: Japan,” evidence record 19512, https://ethics.ai/record/19512 (originally published by OECD).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.